PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate
Condition: Breast Cancer Interventions: Drug: Leuprorelin acetate; Drug: Letrozole; Genetic: MammaPrint Sponsor: Seoul National University Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Genetics | HER2 | Hospitals | Neoadjuvant Therapy | Research